FP-1039

Five Prime Therapeutics Announces Updated Data in Mesothelioma Patients from Ongoing Phase 1b Trial of FP-1039 Presented at 2016 ASCO Annual Meeting
Yahoo
Sat, 06/4/16 - 06:27 pm
Five Prime
ASCO 2016
mesothelioma
FP-1039
Human Genome Pumps Up Its Pipeline
Seeking Alpha
Sat, 03/19/11 - 09:58 am
Human Genome Sciences
FP-1039
Benlysta